Upcoming ACT EU Multi-stakeholder Workshop on ICH E6 R3
As part of the published Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan 2022-2026 and acknowledging the important role of International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Efficiency...
IMPORTANT MESSAGE FROM ACT EU
All clinical trials expected to continue beyond 30 January 2025 must be transitioned to the EU Clinical Trials Regulation (CTR) via the Clinical Trials Information System (CTIS). This date marks the end of a three-year transition period that began when the CTR became...
Update from ACT EU: ACT EU Helpdesk For Non-Commercial Sponsors
[ 💡 🔔 Updates from ACT EU: ACT EU Helpdesk For Non-Commercial Sponsors] ACT EU has established a dedicated helpdesk, which employs different measures to support non-commercial sponsors in navigating the clinical trial landscape in the EU. Currently, the...
ACT EU: ACT EU Helpdesk For Non-Commercial Sponsors
